Xenpozyme 20 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFCQ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,394
Award facts
- Contract value 100% obligated
- $70,393.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $70,393.68 delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for Xenpozyme 20 mg vials, with ultimate completion by April 29, 2026.
The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL.
Quick answers
Who was awarded contract SPE2DR26FFCQ0?
SPE2DR26FFCQ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 8, 2026.
How much is contract SPE2DR26FFCQ0 worth?
The government has obligated $70,394 on SPE2DR26FFCQ0.
Is contract SPE2DR26FFCQ0 an order under another contract?
Yes. SPE2DR26FFCQ0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFCQ0 competed?
The extent of competition for SPE2DR26FFCQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award